ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,572.07
-0.76%
US Tech 100
19,011.60
0.78%
다우존스 지수
41,433.48
-1.14%
Bitcoin
82,506.80
-0.41%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. BioCardia Inc (BCDA) 시세

BioCardia Inc

BioCardia Inc (BCDA)

NASDAQ
2.57
0.03
(1.18%)
마감 12 3월 5:00AM
15분 지연
2.57
0.00
( 0.00% )
시간외 단일가: 5:55PM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
2.57
매수가
2.23
매도가
2.98
거래량
-
0.00 일간 변동폭 0.00
1.625 52주 범위 6.8655
market_cap
11.782M
전일 종가
2.57
개장가
-
최근 거래 시간
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
54,707
발행 주식
4,584,285
배당수익률
-
주가수익률
-1.02
주당순이익(EPS)
-2.52
매출
477k
순이익
-11.57M

BioCardia Inc 정보

BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus o... BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.biocardia.com
본부
Wilmington, Delaware, USA
설립됨
-
BioCardia Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker BCDA. The last closing price for BioCardia was US$2.57. Over the last year, BioCardia shares have traded in a share price range of US$ 1.625 to US$ 6.8655.

BioCardia currently has 4,584,285 shares in issue. The market capitalisation of BioCardia is US$11.78 million. BioCardia has a price to earnings ratio (PE ratio) of -1.02.

BCDA 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
10 3월 2025
BCDA (1.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 3월 2025
BCDA (1.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 3월 2025
BCDA (1.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 3월 2025
BCDA (1.18%)

Form 8-K - Current report
Edgar (US Regulatory)
27 2월 2025
BCDA (1.18%)

Form 8-K - Current report
Edgar (US Regulatory)
13 2월 2025
BCDA (1.18%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.114.471544715452.462.722.4304922.5719358CS
40.156.198347107442.422.951.925529702.50439066CS
120.524.1545893722.072.951.625547072.35406316CS
26-0.12-4.460966542752.693.25841.625735822.56806622CS
52-4.105-61.49812734086.6756.86551.6253209533.90666093CS
156-28.33-91.682847896430.943.79851.62543160414.29715373CS
260-42.43-94.2888888889451291.62555611941.64478936CS

BCDA - Frequently Asked Questions (FAQ)

What is the current BioCardia share price?
The current share price of BioCardia is US$ 2.57
How many BioCardia shares are in issue?
BioCardia has 4,584,285 shares in issue
What is the market cap of BioCardia?
The market capitalisation of BioCardia is USD 11.78M
What is the 1 year trading range for BioCardia share price?
BioCardia has traded in the range of US$ 1.625 to US$ 6.8655 during the past year
What is the PE ratio of BioCardia?
The price to earnings ratio of BioCardia is -1.02
What is the cash to sales ratio of BioCardia?
The cash to sales ratio of BioCardia is 24.69
What is the reporting currency for BioCardia?
BioCardia reports financial results in USD
What is the latest annual turnover for BioCardia?
The latest annual turnover of BioCardia is USD 477k
What is the latest annual profit for BioCardia?
The latest annual profit of BioCardia is USD -11.57M
What is the registered address of BioCardia?
The registered address for BioCardia is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the BioCardia website address?
The website address for BioCardia is www.biocardia.com
Which industry sector does BioCardia operate in?
BioCardia operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AREBAmerican Rebel Holdings Inc
US$ 0.4946
(62.75%)
13.74M
HCTIHealthcare Triangle Inc
US$ 0.47
(44.62%)
9.38M
HFBLHome Federal Bancorp Inc of Louisiana
US$ 17.99
(42.38%)
1
CSPICSP Inc
US$ 22.00
(41.94%)
16
SSPEW Scripps Company
US$ 1.96
(37.06%)
893.81k
RVYLRYVYL Inc
US$ 0.4001
(-54.43%)
2
HEPAHepion Pharmaceuticals Inc
US$ 0.0505
(-39.88%)
6.61M
SYRSSyros Pharmaceuticals Inc
US$ 0.0963
(-29.19%)
1.4M
SERASera Prognostics Inc
US$ 3.01
(-28.67%)
4
ZYXIZynex Inc
US$ 5.08
(-27.43%)
3.09k
STISolidion Technology Inc
US$ 0.1443
(14.43%)
58.17M
AREBAmerican Rebel Holdings Inc
US$ 0.4946
(62.75%)
13.74M
HCTIHealthcare Triangle Inc
US$ 0.47
(44.62%)
9.38M
HEPAHepion Pharmaceuticals Inc
US$ 0.0505
(-39.88%)
6.61M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8.44
(6.70%)
5.98M

BCDA Discussion

게시물 보기
Monksdream Monksdream 3 월 전
BCDA under $2
👍️0
Monksdream Monksdream 5 월 전
BCDA under $3
👍️0
al dean al dean 6 월 전
Yep-feeling trapped. BCDA down a bunch this Friday too, even with new drug approved. Friday seems, in general, to be a take down day as people are doing other things near weekend and MMs can work it down. Stock market is a weird world !
👍️0
Zorro Zorro 6 월 전
WBUY is always a trap. Staying away from anything Asian;)
👍️0
al dean al dean 6 월 전
You have good nose ! Sold all at $3.33 on guess sell limit--surprise. A couple days of shaking and it goes up some more is my guess. Stuck in WBUY at moment as tried to join party as party was breaking up--lol
👍️0
Zorro Zorro 6 월 전
Smelling news here.
👍️0
al dean al dean 6 월 전
Going right direction. WooHoo Turtle speed--but right direction now.
👍️0
al dean al dean 6 월 전
MMs finding some sellers for a while. Maybe I try for more shares.
👍️0
al dean al dean 6 월 전
Looks rather soft today as volume is down. So horde of seller is NOT happening is good. I think MMs get bored in 2 days and it creeps back up--my thoughts. I'm not selling unless a pop happens.
👍️0
Monksdream Monksdream 6 월 전
BCDA under $5
👍️0
NickDanger NickDanger 6 월 전
I think the 7.2mil may come from adding what the warrant holders can do? I don't know. But yes, I think they are going about enlarging the share structure intelligently. We'll see on the 3rd I guess. Weeee!
👍️0
al dean al dean 6 월 전
I made mistake of thinking new shares amounted to 7.2 million. New share amount is 4.8 M As shares priced at $3, this will not dip too far. Some are already added.so not expecting disaster like some stock adding shares.
👍️0
NickDanger NickDanger 6 월 전
Looks like their new share offering will be around $3 per share - https://www.globenewswire.com/news-release/2024/08/30/2938478/0/en/BioCardia-Announces-Pricing-of-Upsized-7-2-Million-Public-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html
👍️0
NickDanger NickDanger 6 월 전
Another 2.4 million issued under the same terms - https://ih.advfn.com/stock-market/NASDAQ/biocardia-BCDA/stock-news/94464814/form-s-1mef-registration-adding-securities-to-pr Hope this puppy can still keep treading water. Tomorrow's Friday, depending on who's buying this they may not want to hold over the weekend.
👍️0
NickDanger NickDanger 6 월 전
Well, those new shares being issued at half price are going to make it dip. Lot more to do with it than people's fear about it. But I've seen a lot of these Otc's, Pinky's and microcap Biopharma's issue a crapload of new shares right after news and a huge pop and then the share price collapses and people are stuck for months. Sometimes they never recover. The fact that BCDA absorbed them and moved into the 4's at end of day is pretty significant imo. The interest in buying it up in the low 3's means significant money likes the future outlook. Weeeeeeee! Microcap Biopharma!
👍️0
it_happens it_happens 6 월 전
I think that maybe people read both releases by now. Climbing up nicely. This never should have dipped so low. Some traders got a good deal today.
👍️ 1
NickDanger NickDanger 6 월 전
Interesting, thx. It looks like it might have legs...
👍️0
PirateLeviathan8 PirateLeviathan8 6 월 전
At the moment, the trend is more towards $4 than $2
And such orders can be found Level 2 almost everywhere, but mostly these are so-called iceberg orders, where you only see a few thousand but there are hundreds of thousands behind them.
But in this day and age of electronic algorithms, this type of trading is relatively pointless and is no longer done.
Today's trading systems replenish certain positions again and again, buy and sell according to corresponding specifications and forward these promptly to the stock exchanges. This is why you can hardly find any relevant orders in the order books these days.
👍️0
it_happens it_happens 6 월 전
I have an L2. Volume is brisk right now. No walls set up on the ASK. 1700 shares is the highest. Most are 100 shares which most likely means the MMs aren't showing all of the shares they are selling at that PPS.
👍️0
NickDanger NickDanger 6 월 전
Do you have Level 2 on this? Curious what the ask prices are for the top 3-4 market makers. Also wondering if someone is holding out for a giant buy order in the $2something range.
👍️0
NickDanger NickDanger 6 월 전
On doing some more research around the inter-webs; Morningstar has given them a 5 star ranking and other ranking sites make it a moderate buy. So, apparently they're not full of crap. If it hangs around $3 for the close I'll be hopeful for it's future. ("it's called an investment", lolzzz thx.)
👍️0
it_happens it_happens 6 월 전
Also, it's not like the offering was needed to keep the lights on. The money gained from the offering will most likely go toward increased production of the approved product. It's called an investment. The company should realize good profits from the investment.
👍️ 1
PirateLeviathan8 PirateLeviathan8 6 월 전
I have traded so many shares in the last few weeks and months that have issued new shares or announced new shares and closed in these huge volumes within the day.

You can see from the trading that the share wants to rise and will rise in line with the positive approval and the expected increase in profits and income.

It is simply our basic evil with these short addresses that are now headlessly beating up on every share that is even slightly up, regardless of whether there is good or bad news.

But this headless beating on shares very often brings the next 100-200% plus in trading the next day, because they then close the open positions as quickly as possible at all costs and then try the game all over again later out of sheer anger.
It is therefore no wonder why so many of them go bust. Well, it's not their money, but only that of their investors in these funds.
👍️0
NickDanger NickDanger 6 월 전
On a more general low float runner note; people always complain about "dilution" in penny stocks. But the reality is, if it's not a complete scam company who are just selling their shares into the pump, they have to issue more shares for there to be an increase in share price with the increase in attention and volume. These things don't really move up much or best case run way up with only a 1.5 million float. If I had got in and was down 30-50% I would just hang around and wait. I'm going to keep an eye on it anyway. An analyst, H.C. Wainright, whoever the hell that is, has put a price target of $25 per share on this thing. So, who knows. cheers!
👍️0
PirateLeviathan8 PirateLeviathan8 6 월 전
With a current volume of 26.6 million, they won't wait a few days to see what happens and then issue new shares days later.
With today's volume, these announced new shares are already included three times or more in the volume and they can therefore be completed in one day and then celebrate the approval accordingly in the price the following days and generate a high increase.
There are only shorts at work here who think they can beat down the price with all their might and completely ignore the approval and the very good news that comes with it.
They have to cover their open positions very quickly otherwise the shot could backfire badly.
👍️0
NickDanger NickDanger 6 월 전
The total shares outstanding are 1.58 million, the float is 1.5 million. https://finviz.com/quote.ashx?t=BCDA&p=d Those issued shares and 2 types of warrants effectively triple the float. The shares can be bought at $2.47, the pre-funded warrants can be exercised immediately at .001. They can issue them at any time and in any amounts they want; so maybe parcel them out over the coming days, but I don't see how it cannot effect the share price in the near term. Just my non-professional, non-expert opinion. If their suite of catheter tools is something really new and different this will probably make everyone money. It's just going to be a buy and hold instead of a flip. I was going to get in this but saw that S-1 and changed my mind. I don't like to buy and hold. But, no one can predict the future. We'll see in the next couple of days. glta
👍️0
it_happens it_happens 6 월 전
Glad you see it the way I do. That 2m shares in a drop in the bucket.
👍️ 1
PirateLeviathan8 PirateLeviathan8 6 월 전
With a trading volume of 22 million, what are 2.6 million new shares, they have long since been traded and the share price even rose further in the pre-market after this announcement.

A few shorts are only trading on this news with the new shares and are completely ignoring the top news.
I am sure that the share will turn around well today.
👍️0
it_happens it_happens 6 월 전
I don't see why the offering of 2,439,024 would tank the PPS the way it did. The offering shouldn't negate the news in the other PR. Maybe it will bounce back today.
👍️0
Invest-in-America Invest-in-America 6 월 전
BCDA: And indeed it DID, Dude; wherefore, a classic TOILET FLUSH on the Public --- as this Firm ramps-up to DUMP yet more shares onto the Wall Street 'playing field'.
👍️0
NickDanger NickDanger 6 월 전
If you're looking at the same screen I am there's a column of "Latest News" just to the right of the message board. The second press release down is a form S-1A released at 6:02am. I believe it has a strong bearing on which direction the price will take.
👍️0
PirateLeviathan8 PirateLeviathan8 6 월 전
The News is top, it will bounce back around 5 bucks +
👍️0
it_happens it_happens 6 월 전
Wonder if it will bounce back over $4. It dropped fast at the bell.
👍️0
Zorro Zorro 6 월 전
Nice subs! Let's make some money.
👍️0
subslover subslover 6 월 전
NEWS_ BioCardia receives FDA clearance for new product
https://www.investing.com/news/company-news/biocardia-receives-fda-clearance-for-new-product-93CH-3592035
👍️0
Helter Skelter Helter Skelter 6 월 전
$BCDA +110% @ 4.62 in premarket on volume...
👍️0
Zorro Zorro 6 월 전
That's what I was thinking as well. Huge market for the drugs approved for sale.
👍️0
NickDanger NickDanger 6 월 전
BCDA 8k - If they issue a press release for this tomorrow morning should get real volume and keep moving up. https://ih.advfn.com/stock-market/NASDAQ/biocardia-BCDA/stock-news/94456844/form-8-k-current-report
👍️0
NickDanger NickDanger 6 월 전
They also submitted this for approval in July - https://www.biospace.com/biocardia-submits-for-fda-approval-of-morph-dna-steerable-introducer-product-family maybe it got approved?
Edit - here it is, looks like it's approved - https://ih.advfn.com/stock-market/NASDAQ/biocardia-BCDA/stock-news/94456844/form-8-k-current-report
👍️0
Invest-in-America Invest-in-America 6 월 전
BCDA; Did what?????? (NOTHING)
👍️0
Monksdream Monksdream 6 월 전
Whoops, I did it, again
👍️0
Monksdream Monksdream 6 월 전
BCDA new 52 low
👍️0
Monksdream Monksdream 7 월 전
BCDA new 52=week low
👍️0
Awl416 Awl416 7 월 전
FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment
👍️0
Monksdream Monksdream 7 월 전
BCDA under $3
👍️0
Monksdream Monksdream 8 월 전
BCDA under $3
👍️0
JB40 JB40 8 월 전
Understand and agree. They get little to no traction on the market. Although, most important imo is they do get traction with the largest health insurer in the country putting millions into BCDA's trials. Bizarre to me that few are paying attention to such a large indication as I'm sure you are aware with them being in such a late stage of their trials. Small burn and only need a small amount of capital to get to the Phase 3 readout. They already have 90% of the Phase 3 BCDA01 data, so I guess we will see what happens with the final data set.
👍️0
murocman murocman 8 월 전
Yes. Have a personal interest as I have heart disease.

Have traded it sporadically.

Disappointed that don’t ever seem to get much traction with this therapy even with good data.

Murocman
👍️0
JB40 JB40 8 월 전
Been tracking this company for years. Anyone else?
👍️0
Monksdream Monksdream 9 월 전
BCDA new 52 week low
👍️0

최근 히스토리

NASDAQ
BCDA
BioCardia
BIT
UC4KTG
Unicredit Bank
USOTC
FLDD
FTAC Emerald Acquisition (QB)
TG
QNT
Quantum
NASDAQ
FUFU
BitFuFu
TG
EB0JJS
Erste Group Bank
BITMOT
844331
Romania Tf 3,375% Fb38 Eur
NASDAQ
FEOSX
Bmo Tactical Global Asse...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지